These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
245 related articles for article (PubMed ID: 34055984)
1. Gold Nanoparticle-Bioconjugated Aminoguanidine Inhibits Glycation Reaction: An Ahmad S; Khan MS; Alouffi S; Khan S; Khan M; Akashah R; Faisal M; Shahab U Biomed Res Int; 2021; 2021():5591851. PubMed ID: 34055984 [TBL] [Abstract][Full Text] [Related]
2. Aminoguanidine inhibits albuminuria, but not the formation of advanced glycation end-products in skin collagen of diabetic rats. Degenhardt TP; Fu MX; Voss E; Reiff K; Neidlein R; Strein K; Thorpe SR; Baynes JW; Reiter R Diabetes Res Clin Pract; 1999 Feb; 43(2):81-9. PubMed ID: 10221660 [TBL] [Abstract][Full Text] [Related]
3. Bioconjugation of gold nanoparticles with aminoguanidine as a potential inhibitor of non-enzymatic glycation reaction. Wang Y; Wang H; Khan MS; Husain FM; Ahmad S; Bian L J Biomol Struct Dyn; 2021 Apr; 39(6):2014-2020. PubMed ID: 32228291 [TBL] [Abstract][Full Text] [Related]
4. Effect of age receptor blocker and/or anti-inflammatory coadministration in relation to glycation, oxidative stress and cytokine production in stz diabetic rats. El-seweidy MM; El-Swefy SE; Ameen RS; Hashem RM Pharmacol Res; 2002 May; 45(5):391-8. PubMed ID: 12123627 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of Advanced Glycation End Products Formation Attenuates Cardiac Electrical and Mechanical Remodeling and Vulnerability to Tachyarrhythmias in Diabetic Rats. Chang GJ; Yeh YH; Chen WJ; Ko YS; Pang JS; Lee HY J Pharmacol Exp Ther; 2019 Jan; 368(1):66-78. PubMed ID: 30381326 [TBL] [Abstract][Full Text] [Related]
6. Role of maltol in advanced glycation end products and free radicals: in-vitro and in-vivo studies. Kang KS; Yamabe N; Kim HY; Yokozawa T J Pharm Pharmacol; 2008 Apr; 60(4):445-52. PubMed ID: 18380916 [TBL] [Abstract][Full Text] [Related]
7. Ellagic acid, a new antiglycating agent: its inhibition of Nϵ-(carboxymethyl)lysine. Muthenna P; Akileshwari C; Reddy GB Biochem J; 2012 Feb; 442(1):221-30. PubMed ID: 22060242 [TBL] [Abstract][Full Text] [Related]
8. Curcumin, Alone or in Combination with Aminoguanidine, Increases Antioxidant Defenses and Glycation Product Detoxification in Streptozotocin-Diabetic Rats: A Therapeutic Strategy to Mitigate Glycoxidative Stress. Lima TFO; Costa MC; Figueiredo ID; Inácio MD; Rodrigues MR; Assis RP; Baviera AM; Brunetti IL Oxid Med Cell Longev; 2020; 2020():1036360. PubMed ID: 32566072 [TBL] [Abstract][Full Text] [Related]
10. Methylglyoxal induces advanced glycation end product (AGEs) formation and dysfunction of PDGF receptor-beta: implications for diabetic atherosclerosis. Cantero AV; Portero-Otín M; Ayala V; Auge N; Sanson M; Elbaz M; Thiers JC; Pamplona R; Salvayre R; Nègre-Salvayre A FASEB J; 2007 Oct; 21(12):3096-106. PubMed ID: 17504976 [TBL] [Abstract][Full Text] [Related]
11. Conversion of Amadori products of the Maillard reaction to N(epsilon)-(carboxymethyl)lysine by short-term heating: possible detection of artifacts by immunohistochemistry. Miki Hayashi C; Nagai R; Miyazaki K; Hayase F; Araki T; Ono T; Horiuchi S Lab Invest; 2002 Jun; 82(6):795-808. PubMed ID: 12065691 [TBL] [Abstract][Full Text] [Related]
12. Advanced glycation end products (AGEs) increase renal lipid accumulation: a pathogenic factor of diabetic nephropathy (DN). Yuan Y; Sun H; Sun Z Lipids Health Dis; 2017 Jun; 16(1):126. PubMed ID: 28659153 [TBL] [Abstract][Full Text] [Related]
13. Renal connective tissue growth factor induction in experimental diabetes is prevented by aminoguanidine. Twigg SM; Cao Z; MCLennan SV; Burns WC; Brammar G; Forbes JM; Cooper ME Endocrinology; 2002 Dec; 143(12):4907-15. PubMed ID: 12446618 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of Methylglyoxal-Induced Histone H1 N Yang L; Li X; Wu Z; Feng C; Zhang T; Dai S; Dong Q J Agric Food Chem; 2018 Jun; 66(23):5812-5820. PubMed ID: 29758984 [TBL] [Abstract][Full Text] [Related]
16. Effect of carnosine, aminoguanidine, and aspirin drops on the prevention of cataracts in diabetic rats. Yan H; Guo Y; Zhang J; Ding Z; Ha W; Harding JJ Mol Vis; 2008; 14():2282-91. PubMed ID: 19081783 [TBL] [Abstract][Full Text] [Related]
17. In Vitro and In Vivo Antiglycation Effects of Connarus ruber Extract. Takenokuchi M; Matsumoto K; Nitta Y; Takasugi R; Inoue Y; Iwai M; Kadoyama K; Yoshida K; Takano-Ohmuro H; Taniguchi T Planta Med; 2022 Oct; 88(12):1026-1035. PubMed ID: 34861700 [TBL] [Abstract][Full Text] [Related]
18. L-Carnitine inhibits protein glycation in vitro and in vivo: evidence for a role in diabetic management. Rajasekar P; Anuradha CV Acta Diabetol; 2007 Jun; 44(2):83-90. PubMed ID: 17530472 [TBL] [Abstract][Full Text] [Related]
19. Advanced glycation end products in extracellular matrix proteins contribute to the failure of sensory nerve regeneration in diabetes. Duran-Jimenez B; Dobler D; Moffatt S; Rabbani N; Streuli CH; Thornalley PJ; Tomlinson DR; Gardiner NJ Diabetes; 2009 Dec; 58(12):2893-903. PubMed ID: 19720799 [TBL] [Abstract][Full Text] [Related]
20. Overexpression of glyoxalase-I reduces hyperglycemia-induced levels of advanced glycation end products and oxidative stress in diabetic rats. Brouwers O; Niessen PM; Ferreira I; Miyata T; Scheffer PG; Teerlink T; Schrauwen P; Brownlee M; Stehouwer CD; Schalkwijk CG J Biol Chem; 2011 Jan; 286(2):1374-80. PubMed ID: 21056979 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]